Seizures after aneurysmal subarachnoid hemorrhage: a systematic review of outcomes (Q38047704)

27 August 2017

Seizures after aneurysmal subarachnoid hemorrhage: a systematic review of outcomes (English)

1 reference

aneurysmal subarachnoid hemorrhage

27 August 2017

1 reference

1 reference

2

Robert M Starke

1 reference

27 August 2017

3

Ricardo J Komotar

1 reference

27 August 2017

1

Daniel M S Raper

1 reference

27 August 2017

5

E Sander Connolly

1 reference

27 August 2017

Rodney Allan

4

1 reference

27 August 2017

25 September 2012

1 reference

27 August 2017

1 reference

27 August 2017

79

1 reference

27 August 2017

5-6

1 reference

27 August 2017

682-690

1 reference

Recent trends in the treatment of cerebral aneurysms: analysis of a nationwide inpatient database

27 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Short-term perioperative anticonvulsant prophylaxis for the surgical treatment of low-risk patients with intracranial aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Ten things we hate about subarachnoid hemorrhage (or, the taming of the aneurysm).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Risk of epilepsy after aneurysm operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Late epilepsy following open surgery for aneurysmal subarachnoid haemorrhage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Onset seizures independently predict poor outcome after subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Seizures after Aneurysmal Subarachnoid Hemorrhage Treated with Coil Embolization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Seizures and Epilepsy following Aneurysmal Subarachnoid Hemorrhage : Incidence and Risk Factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Three-day phenytoin prophylaxis is adequate after subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Predictors and clinical impact of epilepsy after subarachnoid hemorrhage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Anticonvulsant prophylaxis in neurological surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Management of aneurysmal subarachnoid hemorrhage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Epilepsy after craniotomy for intracranial aneurysm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Seizures and CNS hemorrhage: spontaneous intracerebral and aneurysmal subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Epileptic seizures after subarachnoid hemorrhage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Postoperative anticonvulsant prophylaxis for patients treated for cerebral aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Antiepileptic drugs and subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Incidence of seizures or epilepsy after clipping or coiling of ruptured and unruptured cerebral aneurysms in the nationwide inpatient sample database: 2002-2007.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Follow-up study of intracranial aneurysms with special reference to long-term social rehabilitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Late epilepsy after aneurysm operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Phenytoin and cognitive decline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Intracranial aneurysms in patients 18 years of age or under, are they different from aneurysms in adult population?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Seizures and anticonvulsants after aneurysmal subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Characterization of perioperative seizures and epilepsy following aneurysmal subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Risk factors and outcome of seizures after spontaneous aneurysmal subarachnoid hemorrhage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Use of prophylactic anticonvulsants in neurologic critical care: a critical appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Supraorbital eyebrow minicraniotomy for anterior circulation aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Controversies in the management of aneurysmal subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Phenytoin and postoperative epilepsy. A double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Postoperative epilepsy: a double-blind trial of phenytoin after craniotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Neurological and psychosocial outcome 4 to 7 years after subarachnoid hemorrhage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Risk of epilepsy in long-term survivors of surgery for aneurysmal subarachnoid hemorrhage: a population-based study in Iceland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Seizures at the onset of subarachnoid haemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

International subarachnoid trial in the long run: critical evaluation of the long-term follow-up data from the ISAT trial of clipping vs coiling for ruptured intracranial aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

The efficacy of antiepileptic drug prophylaxis in the prevention of early and late seizures following repair of intracranial aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Anticonvulsant prophylaxis and timing of seizures after aneurysmal subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Anticonvulsant drug therapy after aneurysmal subarachnoid hemorrhage: a critically appraised topic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

7 January 2021

SOIL AND STOMACH CANCER

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Epilepsy after operation for aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Improved cognitive outcomes with endovascular coiling of ruptured intracranial aneurysms: neuropsychological outcomes from the International Subarachnoid Aneurysm Trial (ISAT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Utility of levetiracetam in patients with subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Seizures associated with spontaneous subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Epilepsy after operative treatment of ruptured cerebral aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Guglielmi detachable coil embolization of acute intracranial aneurysm: perioperative anatomical and clinical outcome in 403 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

Publication bias in neurosurgery: lessons from series of unruptured aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.08.006

10.1016/J.WNEU.2012.08.006

7 January 2021

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

23022642